nobiletin has been researched along with Breast Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bönisch, H; Haenisch, B; Mayer, R; Müller, CE; Müller, H; Pajeva, IK; Pick, A; Weigt, M; Wiese, M | 1 |
| Jothi, EA; Lv, P; Xiao, Z; Yang, J; Zhang, H | 1 |
| Farkas, ME; Harrington, ME; Labriola, C; Lellupitiyage Don, SS; Lin, HH; Robertson, KL; Taylor, SR | 1 |
| Jian, WJ; Li, Y; Wang, JG; Zhang, J | 1 |
| Androutsopoulos, VP; Arroo, RR; Ruparelia, K; Surichan, S; Tsatsakis, AM | 1 |
| Darvin, P; Kang, DY; Kim, DH; Kim, HJ; Lee, HG; Park, JH; Park, YM; Sp, N; Yang, YM | 1 |
| Chen, C; Nakano, S; Ono, M; Takeshima, M | 1 |
| Hoseini, M; Keramatipour, M; Koohdani, F; Nourbakhsh, M; Rahideh, ST; Shidfar, F; Talebi, S | 1 |
| Androutsopoulos, VP; Arroo, RR; Boarder, MR; Koutala, E; Sifakis, S; Surichan, S; Tsatsakis, A | 1 |
| Ahn, KS; Baek, SH; Chang, IM; Choi, SH; Kim, SH; Kim, SM; Lee, JH; Nam, D; Shim, BS | 1 |
| Ferguson, PJ; Koropatnick, J; Morley, KL | 1 |
11 other study(ies) available for nobiletin and Breast Neoplasms
| Article | Year |
|---|---|
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Hydrogen Bonding; Models, Molecular; Neoplasm Proteins; Quantitative Structure-Activity Relationship | 2011 |
Nobiletin Attenuates Cell Proliferation by Modulating the Activating Protein-1 Signaling Pathway in 7,12-Dimethylbenz[a]anthracene-Induced Mammary Carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Breast Neoplasms; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Female; Flavones; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor AP-1 | 2020 |
Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Circadian Rhythm; Flavones; Humans; Osteosarcoma | 2020 |
Nobiletin promotes the pyroptosis of breast cancer via regulation of miR-200b/JAZF1 axis.
Topics: Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Co-Repressor Proteins; DNA-Binding Proteins; Female; Flavones; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; MicroRNAs; NF-kappa B; Pyroptosis; Signal Transduction; Tetrazolium Salts; Thiazoles; Transfection | 2021 |
Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes.
Topics: Activation, Metabolic; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP1A1; Female; Flavones; Humans; Inhibitory Concentration 50 | 2018 |
Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.
Topics: Adenocarcinoma; Base Sequence; Breast Neoplasms; CD36 Antigens; Cell Line, Tumor; Cell Movement; Cell Survival; Computer Simulation; DNA; Female; Flavones; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Protein Binding; STAT3 Transcription Factor | 2018 |
Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Flavones; Humans; Inhibitory Concentration 50 | 2014 |
Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line.
Topics: Aromatase; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Flavones; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Letrozole; MCF-7 Cells; Nitriles; Structure-Activity Relationship; Triazoles | 2017 |
Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells.
Topics: Adenocarcinoma; Biotransformation; Breast Neoplasms; Cell Proliferation; Citrus; Cytochrome P-450 Enzyme System; Female; Flavones; Humans; MCF-7 Cells | 2012 |
Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Electrophoretic Mobility Shift Assay; Flavones; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; NF-kappa B; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2012 |
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Flavones; G1 Phase; HT29 Cells; Humans; Molecular Structure; Time Factors | 2007 |